Status:
UNKNOWN
Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients
Lead Sponsor:
Magdalena Salcedo
Conditions:
Liver Transplant Infection
Covid19
Eligibility:
All Genders
18-100 years
Brief Summary
This is a prospective study analyzing the development of humoral immune response against SARS-Cov-2 in patients with previous Covid19: the aim is to compare the incidence, titration and evolution of I...
Detailed Description
The liver transplant (HT) recipient population is more susceptible to infections than the general population. Few data are available regarding the incidence and clinical course of SARS-CoV-2 infection...
Eligibility Criteria
Inclusion
- Patients recovered of covid 19 Informed Consent
Exclusion
- Chemotherapy on going Concomitant Autoimmune diseases
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04410471
Start Date
May 29 2020
End Date
June 30 2021
Last Update
June 2 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Victor Fernandez Alonso
Madrid, Spain, 28009
2
Victor Fernández Alonso
Madrid, Spain, 28009